Search - tctmd.com

Displaying 441 - 460 of 699

Sort: Relevancy | Date

News Conference News HRS 2019

ERADICATE-AF: Could Add-on Renal Denervation Give A-fib Ablation a Boost?

Todd Neale

May 10, 2019

News Daily News

Mortality From Heart Failure Increasing in United States

Michael O'Riordan

May 06, 2019

News Daily News

Low-Level Ionizing Radiation May Raise Hypertension Risk

L.A. McKeown

May 03, 2019

News Daily News

Analysis Supports Aiming for Lower BP in Patients With Diabetes, Hypertension

Todd Neale

April 29, 2019

News Daily News

Patients Stop CVD Medications When Their Pharmacy Closes

Michael O'Riordan

April 19, 2019

News Industry News

TriNetX's Real-World Data and Analytics Platform Used to Compare Antihypertensive Treatments and Cardiovascular Events; Findings Published in the Journal of Clinical Hypertension

April 18, 2019

Presentation ARCH 2019

Renal Denervation: Update of Trials

Presenter: Jason Fontana

April 12, 2019

Presentation ARCH 2019

Hypertension Treatment: Current Guidelines and New Treatment Modalities

Presenter: Marcos Rothstein

April 12, 2019

News Daily News

Visit-to-Visit BP Variability Linked to Coronary Plaque Progression, Adverse Outcomes

Todd Neale

April 11, 2019

News Daily News

Digital Tools Show Promise for Helping STEMI and NSTEMI Patients Avoid Readmission

L.A. McKeown

April 09, 2019

News Daily News

Poor Diet Responsible for 11 Million Deaths Annually, With CVD a Leading Cause

Michael O'Riordan

April 04, 2019

News Daily News

Color-Coded Cues and Physician Prompts Boost Evidence-Based Therapy in High-Risk CVD

L.A. McKeown

April 03, 2019

News Daily News

Renal Denervation Lowers BP in Sham-Controlled Studies: Meta-Analysis

Michael O'Riordan

April 02, 2019

News Conference News ACC 2019

Renal Denervation May Lower Treatment Burden, as Well as Blood Pressure: RADIANCE-HTN SOLO

Michael O'Riordan

April 01, 2019

Presentation SIF 2019

When Lightning Strikes Twice

Presenter: Nadia Sutton

March 29, 2019

Presentation CIT 2019

Where I See the Ideal Role for Renal Denervation Therapies

Presenter: Tony Walton

March 28, 2019

News Conference News ACC 2019

Amlodipine the Key Component in Dual BP Therapy in Sub-Saharan Africa: CREOLE

Caitlin E. Cox

March 25, 2019

Presentation ECHO/IMAGING 2019

Echocardiographic Approach to the CHD: Evaluating the Unoperated Adult

Presenter: William R. Miranda

March 24, 2019

News Daily News

FDA: Some Tainted Losartan Must Remain on US Market to Maintain Adequate Access for Patients

L.A. McKeown

March 21, 2019

News Conference News ACC 2019

INFINITY: Aggressive Blood Pressure Lowering May Slow Cerebrovascular Disease in Elderly

L.A. McKeown

March 21, 2019

Advertisement

ERADICATE-AF: Could Add-on Renal Denervation Give A-fib Ablation a Boost?

Mortality From Heart Failure Increasing in United States

Low-Level Ionizing Radiation May Raise Hypertension Risk

Analysis Supports Aiming for Lower BP in Patients With Diabetes, Hypertension

Patients Stop CVD Medications When Their Pharmacy Closes

TriNetX's Real-World Data and Analytics Platform Used to Compare Antihypertensive Treatments and Cardiovascular Events; Findings Published in the Journal of Clinical Hypertension

Renal Denervation: Update of Trials

Hypertension Treatment: Current Guidelines and New Treatment Modalities

Visit-to-Visit BP Variability Linked to Coronary Plaque Progression, Adverse Outcomes

Digital Tools Show Promise for Helping STEMI and NSTEMI Patients Avoid Readmission

Poor Diet Responsible for 11 Million Deaths Annually, With CVD a Leading Cause

Color-Coded Cues and Physician Prompts Boost Evidence-Based Therapy in High-Risk CVD

Renal Denervation Lowers BP in Sham-Controlled Studies: Meta-Analysis

Renal Denervation May Lower Treatment Burden, as Well as Blood Pressure: RADIANCE-HTN SOLO

When Lightning Strikes Twice

Where I See the Ideal Role for Renal Denervation Therapies

Amlodipine the Key Component in Dual BP Therapy in Sub-Saharan Africa: CREOLE

Echocardiographic Approach to the CHD: Evaluating the Unoperated Adult

FDA: Some Tainted Losartan Must Remain on US Market to Maintain Adequate Access for Patients

INFINITY: Aggressive Blood Pressure Lowering May Slow Cerebrovascular Disease in Elderly

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content